Komori
CanBas (4575) · Risk18-employee organization

Reliance on Small Organizations and a Small Number of Key Personnel Driving the Business

First written in FY2016. 4 of 8 entries say "Restated". Latest entry: FY2026.

8entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseWorsenedFY2017 – FY2020RestatedFY2021 – FY20262016: 12017: 120172018: 020182019: 020192020: 120202021: 120212022: 120222023: 120232024: 120242025: 020252026: 12026
Same theme, other companies
Risk of Dependence on Core PersonnelA theme 38 companies write about · 38 as a headwind · 0 as a tailwind

CanBas moved to the "Worse" side of this theme in 2017, 8 years before the typical company in this theme (2025).

The whole theme swung hardest in 2020: 5 of 13 companies on the "Worse" side.

2 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 38 companies compared. The sentences above are computed from all 38.
Full recordFilings, disclosures and news, newest first
  1. FY202618-employee organizationAnnual report

    「The company operates its business from a single location with 18 employees, and in a small, flat organization with a limited number of employees such as ours,」

    The company continues to disclose the risks associated with relying on a small number of business drivers and a small-scale organization, while explicitly stating that it operates with 18 employees.
  2. FY2024RestatedAnnual report

    「In addition, to date the company has conducted its business as a whole, including basic research and research and development, under the direction of Kawabe Takumi (河邊拓己), its founding scientist and the creator and inventor of the technologies that are the source of its competitive strength. Kawabe continues to play a broad and central role in the company’s decision-making and business operations as its Representative Director and President.」

    The company continues to disclose its central dependence, in research and development and management, on Kawabe (河邊拓己), its founding scientist and Representative Director and President.
  3. FY2023RestatedAnnual report

    「In addition, to date the company has conducted its business as a whole, including basic research and research and development, under the direction of Kawabe Takumi (河邊拓己), its founding scientist and the creator and inventor of the technologies that are the source of its competitive strength. Kawabe continues to play a broad and central role in the company’s decision-making and business operations as its Representative Director and President.」

    Although the research and development workforce has increased, the company continues to disclose its central dependence on Kawabe (河邊拓己), its founding scientist and Representative Director and President, as a risk.
  4. FY2022RestatedAnnual report

    「In addition, to date the company has conducted its business as a whole, including basic research and research and development, under the direction of Kawabe Takumi (河邊拓己), its founding scientist and the creator and inventor of the technologies that are the source of its competitive strength.」

    The company continues to disclose its dependence on a limited number of business leaders, including Kawabe (河邊拓己), its founding scientist and Representative Director and President.
  5. FY2021RestatedAnnual report

    「In addition, to date the company has conducted its business as a whole, including basic research and research and development, under the direction of Kawabe Takumi (河邊拓己), its founding scientist and the creator and inventor of the technologies that are the source of its competitive strength.」

    The company continues to disclose its dependence on a limited number of business leaders, including Kawabe (河邊拓己), its founding scientist and Representative Director and President.
  6. FY2020WorsenedAnnual report

    「Our research and development activities are conducted by a relatively small workforce.」

    The company continues to disclose the risk of dependence on a small workforce. The research and development workforce totaled 9 at the end of the fiscal year, down from 11 previously.
  7. FY2017WorsenedAnnual report

    「As of 30 June 2017, our personnel comprised 3 directors excluding Audit and Supervisory Committee members, 4 directors who were Audit and Supervisory Committee members, 10 employees and 1 temporary employee.」

    The total number of employees fell from 13 previously to 10, further reducing the scale of the small organization. The company plans to use outsourcing and partnerships and increase its research and development workforce.
  8. FY2016First statedAnnual report

    「The company is working to strengthen its management structure in order to establish an organization that is not excessively dependent on a limited number of business leaders. However, because it is expected to remain highly dependent on Kawabe Takumi (河邊拓己) for the time being, any difficulty Kawabe encounters in performing the company’s operations for any reason could have a material effect on its business strategy and operating results.」

    In addition to its small workforce of 13 employees, the company identifies its dependence on the Representative Director, President and founding scientist as a risk.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for CanBas yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Reliance on Small Organizations and a Small Number of Key Personnel Driving the Business | CanBas Co.,Ltd. (4575) | Komori